Fitch revises Medline outlook to stable

Fitch Ratings said it revised its outlook for Mozart Holdings, LP and Medline Borrower, LP to stable from negative.

“The revision reflects Medline's improved performance as reflected in its meaningful revenue, EBITDA and cash flow growth. Fitch believes that Medline is capable of growing revenue at approximately 5% or higher and maintaining EBITDA margins to support future deleveraging,” Fitch said in a press release.

Concurrently, the agency affirmed their long-term issuer default ratings at B+ and Medline Borrower's and Medline Co-Issuer, Inc.'s senior secured debt at BB-/RR3 and senior unsecured debt at B-/RR6.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.